Opinion · 23 Sep 2024
Conference abstract
Enhancing bioanlytical selectivity beyond conventional LC/MS/MS
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
B ioanalytical assays for biosimilars, peptides, and small molecules can often exhibit interferences which limit sensitivity and/ or throughput. Unresolved chromatogrphic peaks or high baseline pose challenges in method development requiring more elaborate and lengthy sample preparation and chromatography. Interferences are more likely to be encountered in high sensitivity assays especially with peptides and analogs of natural products. Additional analytical selectivity beyond standard MS/MS is required. Differential mobility is a powerful orthagonal techniqe to LC/MS/MS. Until recently, it has lacked the required performance for rugged and sensitive bioanalysis. SelexION TM Technology from AB Sciex is the first differential mobility interface with the sensitivity, speed, ruggedness, and stability for regulated bioanalysis. It can be used on existing Triple Quadrupole and QTRAP 5500 systems. High Resolution MS (HRMS) is another technique capable of providing enhanced selectivity. It has traditionally been limited to qualitative analysis due to limitations in dynamic range, speed, and sensitivity. It is now gaining acceptance for bioanalytical quantitation since the introduction of the TripleTOF TM 5600 system from AB Sciex, which enables novel HRMS and MS/MS techniques for quantitative analysis, while maintaining compatability with UHPLC. Finally, MS3 is the third option available to achieve additional selectivity. Hybrid QTRAP systems enable the use of MS3 for quantitation by combining a triple quadrupole and a linear ion trap in one instrument. An introduction to these techniques will be presented along with several real life data examples of how they have been used to overcome selectivitychallenges in the bioanalysis of both peptides and small molecules in order to achieve higher throughput and lower limits of quantitation
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 15 Oct 2013
Conventional-QSAR analysis on 1-H, indole,2,3-dione derivatives as selective carboxylesterase inhibitor
Conference abstract · 24 Sep 2018
Parental drug delivery system considerations from formulation to device selection and beyond
Research article · 30 Nov 2020
Enhanced Anti-Inflammatory Effect of Polyherbal Formulation (MKA) Comprising of Three Selected Plants in Lipopolysaccharide (LPS) -Induced Raw 264.7 Macrophage Cell Line
Short communication · 30 Sep 2020
Wound Dressing Selection Is Critical to Enhance Platelet Rich Fibrin Activities in Wound Care
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hesham Ghobarah”
